Brian Babin discusses military and energy policies, foreign influence, and legislation in series of tweets

Brian Babin discusses military and energy policies, foreign influence, and legislation in series of tweets
Brian Babin U.S. House of Representatives from Texas's 36th district — Official U.S. House Headshot
0Comments

U.S. Congressman Brian Babin, currently representing Texas’ 36th district, has recently expressed his political views and legislative activities through a series of tweets. Babin, who has been a member of the U.S. Congress since 2015 after succeeding Steve Stockman, commented on various issues ranging from military priorities to energy policy and international influence in educational institutions.

On March 26, 2025, Babin tweeted about joining a discussion with the Republican Study Committee. “I joined @RepublicanStudy with @RepRalphNorman and @Rep_Clyde to discuss RSC priorities, the new F-47 fighter jet, Trump’s return, and woke judges undermining the President.”

Later the same day, Babin announced his meeting with the newly appointed Secretary of Energy. “I met with @SecretaryWright, our new Secretary of @Energy, who understands what it takes to power America. We’re ready to unleash U.S. energy dominance, drill baby drill, and get back to American prosperity!” This tweet reflects Babin’s support for expanding domestic energy production.

On March 27, 2025, Babin addressed concerns over foreign influence in U.S. universities and legislative measures to counter it. “There’s no such thing as a free lunch! The CCP isn’t handing cash to U.S. universities out of kindness, it’s to buy influence. I just voted for the Deterrent Act to put an end to it.” This tweet highlights his stance on limiting foreign financial engagement in American educational institutions.



Related

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA

Cities located in Chambers County saw an FDA inspection of 1 company in Q1

There was one company in a city associated with Chambers County that received an FDA inspection in the first quarter of 2026, according to the U.S. Food and Drug Administration.

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

FDA conducts Feb. 12 inspection at AMPAC Fine Chemicals Texas, LLC in La Porte

FDA records show an inspection focused on drug quality assurance took place at AMPAC Fine Chemicals Texas, LLC in La Porte on Feb. 12.

Sara Brenner, Principal Deputy Commissioner at FDA

FDA inspects Octapharma Plasma in Pasadena on Feb. 26, finds no required action

The Food and Drug Administration inspected Octapharma Plasma, Inc. in Pasadena on Feb. 26, reviewing blood and blood products, as reflected in data from the agency’s website.